Call customer care on: 0333 358 0200

Mounjaro price increase – what you need to know

If you’re currently prescribed Mounjaro (tirzepatide) for weight management, we want to make you aware of an important update about its cost.

From 1st September 2025, the manufacturer, Eli Lilly, will be significantly increasing the list price of Mounjaro. This change is partly due to new US tariffs and also to bring the UK price more in line with what patients pay in the United States.

What is Mounjaro?

Mounjaro is a prescription-only injectable medication that contains tirzepatide, a dual-acting glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It works by regulating appetite, slowing digestion, and improving the way your body processes sugar.

Originally developed for type 2 diabetes management, Mounjaro has also shown significant effectiveness for weight loss in people who are overweight or living with obesity. Many patients have achieved substantial results when Mounjaro is combined with healthy eating and physical activity.

Can I switch from Mounjaro to Wegovy?

Yes, switching from Mounjaro to Wegovy may be possible, but this will be assessed on a case-by-case basis by your prescribing clinician. Before making the decision to switch, it’s important to consider the following:

  • Washout period required – Before starting Wegovy, you will need to allow 25 days for Mounjaro to clear from your system.
  • Starting dose – Regardless of your previous Mounjaro dose, Wegovy must be started at 0.25mg. This means it may take a few months before you begin to feel the full effects.
  • Your weight loss goals – Depending on how much weight you are aiming to lose, it may be more beneficial to continue with Mounjaro rather than switch.

Benefits of Wegovy

  • Works by targeting GLP-1 receptors, similar to Mounjaro.
  • Clinical trials have shown an average weight loss of 16%, with many patients achieving more.
  • Licensed for weight maintenance, meaning it is safe to continue even after you reach your goal weight.
  • Long-term studies show patients can maintain their weight loss when staying on treatment.
  • Proven cardiovascular benefits, including a significant reduction in the risk of heart attack or stroke.

Switching to Wegovy will be the right decision for some patients, but not for others. Your clinician will guide you through the pros and cons and help you make the choice that’s in your best interest.

What does the price change mean for you?

For now, your prescription cost will remain the same until the new pricing takes effect in September. However, after 1st September 2025, the cost will rise.

To help you prepare, here’s what we recommend:

  • Place your order early – Ordering before the end of August means you’ll secure the current price. If you’re already in treatment, we can arrange multiple orders in advance.
  • Consider alternatives – While Mounjaro is highly effective, other treatments such as Wegovy (semaglutide) may be suitable and are available at lower price points.
  • Stay updated – We’re actively working with other providers to source more affordable options and will share updates as soon as they’re available.

We’re here to help

We understand that a price increase of this scale can cause concern. Our goal is to ensure you have continued access to effective weight management support without unnecessary financial pressure.

If you’d like to place an early order, explore alternative treatments, or discuss your individual options, please get in touch with our team.

Your health and wellbeing remain our priority, and we’re committed to supporting you through this change with clear advice, timely updates, and personalised care.

How it works

Get personalised care
02. Get personalised care

We'll provide you with a tailored treatment plan from a UK registered doctor

Get next day delivery
03. Get next day delivery

Receive genuine medication shipped discreetly to your door